Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.

BACKGROUND: Plasmodium falciparum infection exerts a considerable burden on pregnant women, but less is known about the adverse consequences of Plasmodium vivax infection. METHODS: In Papua, Indonesia, where multiple drug resistance to both species has emerged, we conducted a cross-sectional hospit...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Poespoprodjo, JR, Fobia, W, Kenangalem, E, Lampah, D, Warikar, N, Seal, A, Mcgready, R, Sugiarto, P, Tjitra, E, Anstey, N, Price, R
Natura:	Journal article
Lingua:	English
Pubblicazione:	2008

Documenti analoghi

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
di: Poespoprodjo, JR, et al.
Pubblicazione: (2014)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
di: Tjitra, E, et al.
Pubblicazione: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
di: Tjitra, E, et al.
Pubblicazione: (2008)

MULTIDRUG RESISTANT VIVAX MALARIA: A MAJOR CAUSE OF MORBIDITY IN EARLY LIFE
di: Poespoprodjo, JR, et al.
Pubblicazione: (2008)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
di: Price, R, et al.
Pubblicazione: (2010)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
di: Price, R, et al.
Pubblicazione: (2007)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
di: Tjitra, E, et al.
Pubblicazione: (2007)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
di: Karyana, M, et al.
Pubblicazione: (2008)

Vivax malaria: a major cause of morbidity in early infancy.
di: Poespoprodjo, JR, et al.
Pubblicazione: (2009)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant <it>Plasmodium vivax </it>and <it>Plasmodium falciparum</it>
di: Okoseray Maurits J, et al.
Pubblicazione: (2008-08-01)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
di: Lampah, D, et al.
Pubblicazione: (2011)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
di: Yeo, T, et al.
Pubblicazione: (2010)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
di: Hasugian, A, et al.
Pubblicazione: (2007)

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
di: Salwati, E, et al.
Pubblicazione: (2011)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
di: Karyana, M, et al.
Pubblicazione: (2007)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
di: Ratcliff, A, et al.
Pubblicazione: (2007)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
di: Kho, S, et al.
Pubblicazione: (2016)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
di: Douglas, N, et al.
Pubblicazione: (2014)

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
di: Marfurt, J, et al.
Pubblicazione: (2011)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
di: Setyadi, A, et al.
Pubblicazione: (2019)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
di: Kho, S, et al.
Pubblicazione: (2016)

In vitro and molecular characterisation of multidrug resistant Plasmodium vivax.
di: Suwanarusk, R, et al.
Pubblicazione: (2008)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia.
di: Daniel A Lampah, et al.
Pubblicazione: (2011-06-01)

Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.
di: Woodberry, T, et al.
Pubblicazione: (2008)

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.
di: Suwanarusk, R, et al.
Pubblicazione: (2008)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
di: Kenangalem, E, et al.
Pubblicazione: (2017)

Limitations of microscopy to differentiate <it>Plasmodium</it> species in a region co-endemic for <it>Plasmodium falciparum</it>, <it>Plasmodium vivax</it> and <it>Plasmodium knowlesi</it>
di: Barber Bridget E, et al.
Pubblicazione: (2013-01-01)

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
di: Marfurt, J, et al.
Pubblicazione: (2012)

The anaemia of Plasmodium vivax malaria.
di: Douglas, N, et al.
Pubblicazione: (2012)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
di: Agus Setyadi, et al.
Pubblicazione: (2019-04-01)

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
di: Marfurt, J, et al.
Pubblicazione: (2011)

High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions.
di: Handayani, S, et al.
Pubblicazione: (2009)

Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.
di: Kho, S, et al.
Pubblicazione: (2015)

Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
di: Russell, B, et al.
Pubblicazione: (2008)

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.
di: Douglas, N, et al.
Pubblicazione: (2013)

Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
di: Anstey, N, et al.
Pubblicazione: (2012)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
di: Poespoprodjo, J, et al.
Pubblicazione: (2015)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
di: Kho, S, et al.
Pubblicazione: (2018)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
di: Thriemer, K, et al.
Pubblicazione: (2020)

Plasmodium malariae infection associated with a high burden of anemia: a hospital-based surveillance study
di: Langford, S, et al.
Pubblicazione: (2015)